SOCS3 and liver cancer: Therefore, our findings suggested that reduced SOCS3 expression coupled with enhanced STAT3 phosphorylation activated the IL6/JAK/STAT signaling pathway, resulting in an elevated incidence of primary liver cancer in FXR−/− mice.